# RMA Long Island IVF – FDA Inspection, Feb 9, 2024

Source: https://www.keypedia.com/records/fda_inspections/rma-long-island-ivf/d3a572d3-1795-41a8-840a-52327db22793
Source feed: FDA_Inspections

> FDA inspection 1229041 of RMA Long Island IVF, February 09, 2024. Classification: No Action Indicated (NAI). 3 citations under 21 CFR part 1271. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229041
- Company Name: RMA Long Island IVF
- Inspection Date: 2024-02-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1163524 - 2022-03-01
- FDA Inspection 1076523 - 2018-12-13
- FDA Inspection 994705 - 2016-12-20
- FDA Inspection 900033 - 2014-10-16
- [FDA Inspection 813876 - 2013-01-11](https://www.keypedia.com/records/fda_inspections/rma-long-island-ivf/c1ff5ba7-43b7-4cb5-9e82-211c3a546feb)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/rma-long-island-ivf/cd54c3fa-c54b-41c1-a844-8eafdb85b4f3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d